Compounds > 1,2-distearoyllecithin
Page last updated: 2024-08-24

1,2-distearoyllecithin and arsenic

1,2-distearoyllecithin has been researched along with arsenic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antimisiaris, SG; Fatouros, DG; Frederik, P; Gortzi, O; Ioannou, PV; Piperoudi, S1
Antimisiaris, SG; Fatouros, D; Frederik, P; Ioannou, PV; Piperoudi, S1
Antimisiaris, SG; Giannopoulou, E; Haikou, M; Ioannou, PV; Klepetsanis, P; Zagana, P1

Other Studies

3 other study(ies) available for 1,2-distearoyllecithin and arsenic

ArticleYear
Physical stability of sonicated arsonoliposomes: effect of calcium ions.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:1

    Topics: Arsenicals; Calcium; Cholesterol; Cryoelectron Microscopy; Drug Stability; Edetic Acid; Electrochemistry; Excipients; Liposomes; Nephelometry and Turbidimetry; Particle Size; Phosphatidylcholines; Ultrasonics

2005
Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles.
    Chemistry and physics of lipids, 2006, Volume: 139, Issue:2

    Topics: Arsenic; Chemical Phenomena; Chemistry, Physical; Cholesterol; Lipids; Liposomes; Membranes, Artificial; Palmitic Acid; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Time Factors

2006
In vivo distribution of arsonoliposomes: effect of vesicle lipid composition.
    International journal of pharmaceutics, 2008, Jan-22, Volume: 347, Issue:1-2

    Topics: Animals; Antiparasitic Agents; Arsenic; Arsenites; Biological Availability; Cholesterol; Female; Injections, Intraperitoneal; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Palmitates; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Static Electricity; Surface Properties; Tissue Distribution

2008